Types of Cellulitis and Management
Cellulitis should be classified primarily as purulent versus non-purulent, as this distinction drives antibiotic selection—with non-purulent cellulitis treated with beta-lactams targeting streptococci and methicillin-sensitive S. aureus, while purulent forms require MRSA coverage. 1
Classification Framework
The most clinically relevant classification divides cellulitis into:
Non-Purulent Cellulitis (Most Common)
- Presents with acute erythema, warmth, swelling, and tenderness without abscess or purulent drainage 2
- Caused by β-hemolytic streptococci (Group A, B, C, or G) in 85% of cases or methicillin-sensitive S. aureus 1, 3
- Pathogen isolation occurs in <20% of cases, leaving diagnosis unconfirmed 80% of the time 1
Purulent Cellulitis
- Associated with abscess formation or purulent drainage
- Higher likelihood of S. aureus, including MRSA
- Requires different antibiotic coverage
Anatomic/Special Subtypes Requiring Modified Management:
Facial Cellulitis (especially pediatric):
- In children with fever >38.5°C AND WBC >15,000/mm³, consider H. influenzae 4
- Higher risk for bacteremia and septic complications
- Requires blood cultures and broader initial coverage
Necrotizing Fasciitis:
- Surgical emergency requiring immediate debridement 1
- Presents with severe pain disproportionate to exam, rapid progression, systemic toxicity
- Requires broad-spectrum IV antibiotics plus urgent surgical consultation
Bite-Related Cellulitis:
- Polymicrobial including anaerobes
- Requires amoxicillin-clavulanate or alternative covering oral flora
Diabetic Foot Cellulitis:
- Often polymicrobial with higher MRSA rates
- Requires assessment for osteomyelitis
- May need broader coverage
Recommended Management Algorithm
Step 1: Confirm True Cellulitis vs. Pseudocellulitis
Critical pitfall: Many conditions mimic cellulitis and do not require antibiotics 2:
- Venous stasis dermatitis (bilateral, chronic, brown pigmentation)
- Contact dermatitis/eczema (pruritic, not acutely tender)
- Lymphedema (chronic swelling, skin changes)
- Deep vein thrombosis (unilateral leg swelling)
Step 2: Classify as Purulent vs. Non-Purulent
Step 3: Antibiotic Selection for Non-Purulent Cellulitis
First-line for uncomplicated cases 1, 2, 5:
- Penicillin, amoxicillin, or cephalexin (e.g., cephalexin 500mg QID)
- Do NOT routinely add MRSA coverage despite rising community-acquired MRSA rates 2
Add MRSA coverage ONLY if specific risk factors present 5:
- Athletes, children in daycare, men who have sex with men
- Prisoners, military recruits, long-term care residents
- Prior MRSA infection/colonization
- IV drug users
- Purulent drainage present
MRSA-active options when indicated:
- Trimethoprim-sulfamethoxazole plus cephalexin
- Doxycycline
- Clindamycin (if local resistance <10%)
Step 4: Duration and Monitoring
Treatment duration: 5 days is sufficient 5
- Extend only if symptoms not improved at 5 days
- Failure to improve should prompt consideration of:
- Resistant organisms
- Pseudocellulitis (wrong diagnosis)
- Underlying complications (immunosuppression, chronic liver/kidney disease)
Step 5: Address Predisposing Factors to Prevent Recurrence
Key modifiable risk factors 1, 6:
- Edema/lymphedema: Consider compression therapy (can be started within 24 hours of antibiotics without worsening infection) 7
- Tinea pedis: Treat fungal infections
- Skin barrier disruption: Optimize wound care, moisturize dry skin
- Obesity: Weight management counseling
- Venous insufficiency: Compression stockings long-term
Important Caveats
The diagnostic challenge: Since cultures are positive in only 15-20% of cases 1, 5, treatment remains largely empiric based on clinical presentation. This underscores the importance of:
- Accurate clinical diagnosis to avoid unnecessary antibiotics
- Recognition that streptococci remain the predominant pathogen despite inability to culture
- Resistance to the temptation to broaden coverage without specific indications
Recurrence is common 1, 6—addressing underlying risk factors is as important as acute antibiotic treatment for long-term outcomes and quality of life.